Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell isolation

E J Shpall1, A Gee, P J Cagnoni

  • 1University of Colorado, Denver, USA.

Current Opinion in Hematology
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A perspective on ABO incompatible transplantation.

Human immunology·2026
Same author

An examination of the use of standard operating procedures on family-operated farms.

JDS communications·2025
Same author

Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports.

Psychological medicine·2024
Same author

The factors contributing to better workplaces for farmers on pasture-based dairy farms.

Journal of dairy science·2024
Same author

An examination of labor time-use on spring-calving dairy farms in Ireland.

Journal of dairy science·2022
Same author

Estimating the effect of different work practices and technologies on labor efficiency within pasture-based dairy systems.

Journal of dairy science·2022
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

High-dose chemotherapy requires stem cell support, but tumor cells in grafts can cause relapse. CD34-selection techniques effectively remove tumor cells, potentially improving outcomes in cancer treatment.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • High-dose chemotherapy with autologous hematopoietic progenitor cell support is a common cancer treatment.
  • A significant challenge is the risk of autograft contamination with clonogenic tumor cells, leading to disease relapse.
  • Positive selection techniques aim to mitigate this risk by isolating stem cells.

Purpose of the Study:

  • To evaluate the efficacy of positive selection techniques in reducing tumor cell contamination in autografts.
  • To assess the impact of these procedures on hematopoietic progenitor cell engraftment.
  • To explore additional applications of CD34-selection in stem cell transplantation.

Main Methods:

  • Utilizing positive selection methods to isolate CD34+ hematopoietic stem cells.

Related Experiment Videos

  • Assessing tumor cell depletion levels through quantitative analysis.
  • Monitoring engraftment and clinical outcomes post-transplantation.

    • Main Results:

    • CD34-selection procedures have demonstrated significant tumor cell depletion, ranging from 2 to 7 logs.
    • These techniques have not impaired hematopoietic progenitor cell engraftment in preliminary studies.
    • Further applications include ex vivo expansion, gene transfer, and T-cell depletion for allogeneic grafts.

    Conclusions:

    • CD34-selection is a promising strategy to reduce tumor cell contamination in autologous stem cell transplantation.
    • While engraftment is preserved, long-term clinical benefit requires further evaluation.
    • This technology holds potential for improving various aspects of stem cell transplantation, including reducing graft-versus-host disease.